SUBSCRIBE
SUBSCRIBE

Postmarket research

Drug Development
Botox Shots May Help Ward Off Migraines, Headache Care Center Study Finds
July 14, 2008
 · 
1 min read
Drug Development
European Molecular Biology Laboratory Scientists Predict New Uses for Existing Drugs from their Side Effects
July 11, 2008
 · 
1 min read
Drug Development
American Academy of Pediatrics Recommends Cholesterol Drugs for Kids
July 7, 2008
 · 
1 min read
Drug Development
Baylor College of Medicine Led Research Finds Asthma Risk Increases in Children Treated for HIV
July 3, 2008
 · 
1 min read
Drug Development
Texas A&M University Study Finds Watermelon Has Effects Similar to Viagra
July 3, 2008
 · 
1 min read
Drug Development
Transplant Drug May Ease Disorder Linked to Autism, University of California, Los Angeles (UCLA) Scientists Find
July 1, 2008
 · 
1 min read
Drug Development
Drug Helps Heroin Addicts Stay Clean in Yale University School Of Medicine Study
June 30, 2008
 · 
1 min read
Drug Development
Athletes Use Pfizer Inc.'s (JOBS) Viagra for a Competitive Edge, World Anti-Doping Agency Experts Say
June 27, 2008
 · 
1 min read
Drug Development
ADHD Gene Linked to Disease Severity But Doesn’t Predict Response to Drugs, Douglas Mental Health University Institute Scientists Find
June 26, 2008
 · 
1 min read
Drug Development
Parkinson’s Drugs Increase Risk of Impulse Disorders, Toronto Western Hospital Researchers Find
June 26, 2008
 · 
1 min read
Load More
PRESS RELEASES
Drug Development
Novartis AG’s Afinitor® Fails Phase 3 Liver Cancer Trial
August 7, 2013
 · 
6 min read
Drug Development
New Retrospective Analysis on Galderma Laboratories’ Differin® Gel, 0.3% in Adult Female Acne Patients
August 1, 2013
 · 
1 min read
Drug Development
Celgene International Sárl Release: Study of REVLIMID® (lenalidomide) in Patients with High-Risk Asymptomatic Smoldering Multiple Myeloma Published in The New England Journal of Medicine
August 1, 2013
 · 
1 min read
Drug Development
AstraZeneca PLC Release: New Sub-Analysis of PLATO ACS Study Suggests Patient Types and Stent Types Had No Impact on Findings of Reduced Rate of Stent Thrombosis With BRILINTA (ticagrelor)
July 31, 2013
 · 
1 min read
Drug Development
Deja Vu: Second Probe Finds Manipulated Trial Data for Novartis AG Drug
July 31, 2013
 · 
1 min read
Drug Development
European Medicines Agency Approves SmPC Change to Baxter International, Inc.’s ADVATE to Include Information on PK-Guided Dosing Study
July 22, 2013
 · 
1 min read
Drug Development
Roche’s Avastin as Good as Novartis AG’s Lucentis for AMD
July 19, 2013
 · 
1 min read
Drug Development
Pacira Pharmaceuticals, Inc. Release: New Study Shows Significant Reduction in Opioids, Length of Hospital Stay and Cost of Care for Patients Receiving EXPAREL® as the Foundation of a Multimodal Postsurgical Pain Regimen
July 18, 2013
 · 
1 min read
Drug Development
Boehringer Ingelheim Corporation Release: Benefits of Pradaxa® Maintained in Difficult to Treat Patients With Atrial Fibrillation and Symptomatic Heart Failure
July 16, 2013
 · 
1 min read
Drug Development
Novartis AG Drug Study Data Manipulated: Kyoto Prefectrual University of Medicine
July 12, 2013
 · 
1 min read
Drug Development
Celgene Corporation’s Revlimid Improves Survival in Blood Cancer Patients
July 11, 2013
 · 
1 min read
Drug Development
Baxter International, Inc. Presents ADVATE Data on Prophylaxis Management and Efficacy for Hemophilia A Patients
July 8, 2013
 · 
1 min read
Drug Development
Merck & Co., Inc. Release: FDA Approves New U.S. Labeling for ISENTRESS® (raltegravir) to Include 240-Week Results From STARTMRK Study of ISENTRESS Containing Regimen in Previously Untreated HIV-1 Infected Adult Patients
July 2, 2013
 · 
1 min read
Drug Development
Bristol-Myers Squibb Company, Pfizer Inc.'s Eliquis Equal To Warfarin to Halt Blood Clots
July 1, 2013
 · 
13 min read
Drug Development
Access Pharmaceuticals Announces Positive Top-Line Data From MuGard™ Phase IV Clinical Trial In Oral Mucositis Patients Presented At MASCC/ISOO 2013 Symposium
June 27, 2013
 · 
5 min read
Drug Development
Acorda Therapeutics Release: First Study of Diazepam Nasal Spray in People With Epilepsy Shows Feasibility of Dosing During Seizure
June 26, 2013
 · 
1 min read
Drug Development
Merck & Co., Inc. Release: New Analysis Shows That Patients With Type 2 Diabetes and Mild Renal Impairment Had Similar Improvement in Blood Sugar Control and Experienced Less Hypoglycemia With JANUVIA® (sitagliptin) Compared to Sulfonylurea
June 24, 2013
 · 
7 min read
Drug Development
Eisai Company, Ltd. Confirms Therapeutic Effects of Lenvatinib in Patients With Melanoma in Strategic Collaboration With Quintiles, Inc. to Develop Eisai Anticancer Compounds
June 19, 2013
 · 
1 min read
Drug Development
VIVUS, Inc. Study Shows ED Drug Stendra Effective in 15 Minutes
June 19, 2013
 · 
6 min read
Drug Development
A Bristol-Myers Squibb Company and AstraZeneca PLC Diabetes Trial is a “Dud”
June 19, 2013
 · 
12 min read
Load More